Modified mammalian cells

TW202639840APending Publication Date: 2026-10-01GENENTECH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115105636
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-03-01
Filing Date
2021-03-26
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001079350_001
    Figure TWG2TA001079350_001
  • Figure TWG2TA001079350_002
    Figure TWG2TA001079350_002
  • Figure TWG2TA001079350_003
    Figure TWG2TA001079350_003
Patent Text Reader

Abstract

The present disclosure relates to methods, cells, and compositions for producing a product of interest, e.g., a recombinant protein. In particular, the present disclosure provides improved mammalian cells expressing the product of interest, where the cells (e.g., Chinese Hamster Ovary (CHO) cells) have reduced or eliminated activity, e.g., expression, of certain host cell proteins, e.g., enzymes including, but not limited to, certain lipases, esterases, and / or hydrolases.
Need to check novelty before this filing date? Find Prior Art